Lynda Charters on Muck Rack

Lynda Charters

Verified
Framingham
As seen in: Modern Retina, Ophthalmology Times, Duke University, EIN News, NewsBreak, American Journal of Managed Care, Modern Medicine, Ophthalmology Times Europe, Drug Topics, Optometry Times, CGTLive
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Lynda

Contact Lynda, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Tinlarebant earns Swiss orphan drug status for Stargardt disease

|
By Martin Harp , Lynda Charters , Siegfried Priglinger
| Modern Retina
Swissmedic, the Swiss Agency for Therapeutic Products, has granted orphan drug status (ODS) to tinlarebant (Belite Bio) for the treatment of Stargardt disease type 1 (STGD1), an inherited macular dystrophy for which no approved pharmacologic therapy currently exists anywhere in the world.
Open in Who Shared View Duplicates (2) Issue with article?

Biogen completes acquisition of Apellis Pharmaceuticals

|
By Martin Harp, Lynda Charters , Siegfried Priglinger
| Modern Retina
The ownership of pegcetacoplan intravitreal injection (SYFOVRE; Apellis Pharmaceuticals), the approved treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD), has changed hands. Biogen Inc.
Open in Who Shared Issue with article?

Intracortical visual prosthesis: A new chapter in advancing visual restoration

|
By Lynda Charters , Siegfried Priglinger, Sheryl Stevenson 
| Modern Retina
The third implantation of the Intracortical Visual Prosthesis (ICVP) in a blind patient has been completed successfully, according to a press release issued by the Illinois Institute of Technology, Chicago. The device is described as “a wireless brain implant designed to provide artificial vision for people with total blindness by bypassing the eyes and optic nerves and connecting directly to the brain’s visual cortex.” The surgery was performed at Rush University Medical Center, Chicago.
Open in Who Shared Issue with article?
See all 579 licensed articles (3,718 Total)

Actions

Share this page

Get in touch with Lynda

Contact Lynda, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified